Wuhan General Group (China), Inc. (WUHN)
OTCMKTS
· Delayed Price · Currency is USD
0.0005
+0.0001 (25.00%)
At close: Mar 3, 2026
Wuhan General Group (China) Company Description
Wuhan General Group (China), Inc., a nutraceutical biotechnology company focused on alternative plant-based cannabinoids and psilocybin medical research.
The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others.
Wuhan General Group (China), Inc. is headquartered in Reno, Nevada.
Wuhan General Group (China), Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 700 |
| CEO | Jeffrey Robinson |
Contact Details
Address: 401 Ryland St. Ste 200-A Reno, Nevada 89502 United States | |
| Phone | 782 413 5457 |
| Website | wuhn.org |
Stock Details
| Ticker Symbol | WUHN |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US9825691051 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jeffrey Robinson | Founder, Chairman and Chief Executive Officer |
| Carol Pan | Principal Financial Officer, Principal Accounting Officer and Treasurer |
| Willem Jonker | Chief Operating Officer |
| Dr. Hyder Ali Khoja A.Ag., M.Sc., Ph.D. | Chief Scientific Officer |
| Shivani Subudhi | Head of Marketing |
| Huang Zhaoqi | Vice General Manager of Turbine and Director |
| Dr. Anna Leralta Morera | Chief Medical Officer |
| Samuel Williams | Head of Food Formulations and Functional Foods |
| Clementine Toto | Head of African Aromatherapy |
| Nicola Royce | Managing Director of M2Biome |